Industry News
MS researchers win Thermo Scientific Cellome Award
Thermo Fisher Scientific has presented its 2014 Cellome Award to the authors of the article 'A regenerative approach to the treatment of multiple sclerosis', featured in the October 2013 issue of Nature. [ + ]
Call for an Australian Brain initiative and bionic brain
Health Minister Peter Dutton today launched the 'Inspiring smarter brain research in Australia' report at Parliament House, Canberra. The report contains recommendations from a High Flyers Think Tank hosted by the Australian Academy of Science in Melbourne last year. [ + ]
Prima signs first licence deal for CVac
Prima Biomed (ASX:PRR) has finalised a licensing agreement with Israel's Neopharm covering CVac, Prima's treatment candidate under development for ovarian cancer. [ + ]
CTx gets largest share of CRC funding round
The government has allocated $186m for the 16th round of the CRC program, and the Cancer Therapeutics CRC is the top beneficiary. [ + ]
Alchemia names new CEO, narrows 1H14 loss
Alchemia (ASX:ACL) has selected COO Thomas Liquard to replace Charles Walker as CEO and announced a slimmer 1H14 net loss of $5.5m. [ + ]
Prizes for stem cell research
Two new $50,000 prizes for stem cell researchers. [ + ]
Giant Magellan Telescope passes design and construction reviews
The Giant Magellan Telescope (GMT) project has passed two major expert reviews over its design and construction. This clears the way for the project to proceed towards construction approval. [ + ]
Garlic neutralises resistant bacteria
A researcher at the University of Copenhagen has written his PhD thesis on the positive properties of garlic, with particular emphasis on its effect against bacteria. [ + ]
Successful phase 2 results in Huntington disease trial
Prana Biotechnology has announced the results of its phase 2 clinical trial investigating the drug PBT2 as a treatment for Huntington disease. [ + ]
Prima adds veteran oncologist to advisory board
Prima BioMed (ASX:PRR) has appointed leading ovarian cancer researcher Dr Bradley Monk to its scientific advisory board, and revealed it narrowed its 1H14 loss by 26%. [ + ]
Mesoblast wins key cardiovascular patent in EU
Mesoblast (ASX:MSB) has secured a European patent giving it exclusive rights to use its MPCs and MSCs to treat cardiac and vascular conditions such as heart failure and stroke. [ + ]
Simavita commences trading on ASX
Simavita (ASX:SVA) has commenced trading on the ASX, as the company gears up for the US launch of its Smart Incontinence Management product. [ + ]
Stem cell competition caught on tape
The epithelial lining of the small intestine needs to be regenerated by stem cells every few days in order to stay functional. Researchers from the Hubrecht Institute have captured recordings of these stem cells in living mice. [ + ]
Potential new approach to treating melanoma
Blocking the delivery of amino acids to melanoma cells may provide another way of tackling this difficult-to-treat disease. [ + ]
Funding for medical research
The latest NHMRC funding round will see $133 million allocated to grant support for medical research. [ + ]
